| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/17/2002 | WO2002004402A1 Ester derivatives |
| 01/17/2002 | WO2001060826A3 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 01/17/2002 | WO2001051572A3 Novel colorants, colorant stabilizers, ink compositions, and improved methods of making the same |
| 01/17/2002 | WO2001047922A3 Azaindoles |
| 01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
| 01/17/2002 | US20020007057 Methods of making cross-bridged macropolycycles |
| 01/17/2002 | CA2415468A1 Ester derivatives |
| 01/17/2002 | CA2415174A1 Methods and kits for the detection of arginine compounds |
| 01/17/2002 | CA2413651A1 Pyrrolo¬3,4-d|pyrimidines as corticotropin releasing factor (crf) antagonists |
| 01/16/2002 | EP1171443A1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP0680964B1 PYRROLO [3,2-e]INDOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE |
| 01/16/2002 | EP0638075B1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 01/16/2002 | CN1331694A Antihistaminic spiro compounds |
| 01/16/2002 | CN1331693A 1,2-annelated quinoline derivatives |
| 01/16/2002 | CN1331678A Synthesis of phenolic monomers contg. imide or diimide moieties and high heat carbonate polymers prepared therefrom |
| 01/16/2002 | CN1331677A Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331080A Syntehsis and activity of triazolo-pyrimido-thioacetyl hydrazone compounds |
| 01/16/2002 | CN1331079A Synthesis and activity of diheterocyclic compounds |
| 01/15/2002 | US6339086 Administering n-desmethylzopiclone, or its pharmaceutically acceptable salt, solvate, hydrate, or clathrate for prophylaxis or therapy of anxiety |
| 01/10/2002 | WO2002002584A1 Base analogues |
| 01/10/2002 | WO2002002564A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | WO2002002563A2 Substituted-triazolopyrimidines as anticancer agents |
| 01/10/2002 | WO2002002562A2 Heteropolycyclic inhibitors |
| 01/10/2002 | WO2002002550A1 Novel pyrazinone derivatives |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002538A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen |
| 01/10/2002 | WO2002002533A1 Propane-1,3-dione derivatives |
| 01/10/2002 | WO2002002519A2 THROMBIN OR FACTOR Xa INHIBITORS |
| 01/10/2002 | WO2002002118A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | WO2001051042A3 Treatment of diabetic ulcers |
| 01/10/2002 | WO2001034603A3 Bicyclic and tricyclic heteroaromatic compounds |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | DE10031584A1 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine 5-aminoalkyl-pyrazolo [4,3-d] pyrimidines |
| 01/10/2002 | DE10019714A1 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 01/10/2002 | CA2414885A1 Heteropolycyclic inhibitors |
| 01/10/2002 | CA2414352A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | CA2413802A1 Substituted-triazolopyrimidines as anticancer agents |
| 01/10/2002 | CA2413241A1 Thrombin or factor xa inhibitors |
| 01/10/2002 | CA2413002A1 Novel pyrazinone derivatives |
| 01/10/2002 | CA2412292A1 Base analogues |
| 01/10/2002 | CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | CA2410945A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/09/2002 | CN1330706A Detergent compositions or components |
| 01/09/2002 | CN1330654A 4,5-pyrrolo-oxindoles |
| 01/09/2002 | CN1330653A 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 01/09/2002 | CN1330652A 2,3,4,4-tetrahydro-1H-pyrazino (1,2-a) quinoxalin-5(6H) one deivatives being 5HT2C agonists |
| 01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
| 01/09/2002 | CN1330069A Substituted 2-benzo [c] furanone compound, its preparing process and medicinal composition containing it |
| 01/09/2002 | CN1330065A Intermediate for preparing enantiomorph pure indol-carbocylic acids and its active derivative |
| 01/08/2002 | US6337395 Selenium derivatives of porphryn |
| 01/08/2002 | US6337331 Triazolo-pyrimidine as ligands for GABA receptors |
| 01/08/2002 | CA2080140C Photodynamic plant defoliants and chlorophyll biosynthesis modulators |
| 01/03/2002 | WO2002000662A1 Improvements in and relating to chromophores |
| 01/03/2002 | WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| 01/03/2002 | WO2002000660A1 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 01/03/2002 | WO2002000657A2 Condensed pyrazindione derivatives |
| 01/03/2002 | WO2002000655A1 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor xa inhibitors |
| 01/03/2002 | WO2002000654A1 Melanocortin receptor ligands |
| 01/03/2002 | WO2002000653A2 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | WO2002000638A2 Substituted phthalides as anti-convulsive drugs |
| 01/03/2002 | WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/03/2002 | WO2002000631A2 Benzhydryl derivatives |
| 01/03/2002 | WO2002000629A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | WO2002000621A1 Compounds exhibiting x-type spla2 inhibiting effect |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | WO2002000257A1 Remedies for alzheimer's disease |
| 01/03/2002 | WO2002000256A1 Remedies for cirrhosis |
| 01/03/2002 | WO2002000255A1 Remedies for cancer |
| 01/03/2002 | WO2001070744A3 Process for the preparation of midazolam |
| 01/03/2002 | WO2001044260A3 Novel purines |
| 01/03/2002 | WO2001044247A3 Agents and methods for the treatment of proliferative diseases |
| 01/03/2002 | US20020002178 Antiproliferative, -carcinogenic agents, antiinflammatory and -arthritis agents; neurodegenerative diseases, e.g., Alzheimer's disease; cardiovascular disorders; viricides; fungicides |
| 01/03/2002 | US20020002169 Protein kinase inhibitors |
| 01/03/2002 | US20020002165 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 01/03/2002 | US20020002161 5-HT ligands used to treat central nervous system disorders |
| 01/03/2002 | US20020002145 Adenosine A2A receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 01/03/2002 | US20020002142 Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation |
| 01/03/2002 | DE10030375A1 Verwendung von MTP-Inhibitoren zur Senkung von ppTRL Use of MTP inhibitors to reduce ppTRL |
| 01/03/2002 | DE10029139A1 Verfahren zur Herstellung von Amiden oder Estern A process for producing amides or esters |
| 01/03/2002 | CA2414089A1 Improvements in and relating to chromophores |
| 01/03/2002 | CA2413752A1 Substituted phthalides as anti-convulsive drugs |
| 01/03/2002 | CA2413683A1 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | CA2412640A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 01/03/2002 | CA2412563A1 Melanocortin receptor ligands |
| 01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/03/2002 | CA2410393A1 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor xa inhibitors |
| 01/02/2002 | EP1166784A1 Inhibitors for vascular reconstriction after angioplasty |
| 01/02/2002 | EP1165564A2 Process for preparing inhibitors of nucleoside metabolism |
| 01/02/2002 | EP1165563A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 01/02/2002 | EP1165562A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/02/2002 | EP1165559A1 1,4-diazabicyclo 3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics |